Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit

BACKGROUND: Long-acting bronchodilators are central in the pharmacological management of patients with chronic obstructive pulmonary disease (COPD). The aim of this systematic review is to provide an overview of the studies evaluating the safety and clinical efficacy of inhaled glycopyrronium bromid...

Descripción completa

Detalles Bibliográficos
Autor principal: Ulrik, Charlotte Suppli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461699/
https://www.ncbi.nlm.nih.gov/pubmed/23055716
http://dx.doi.org/10.2147/COPD.S35990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461699/
https://www.ncbi.nlm.nih.gov/pubmed/23055716
http://dx.doi.org/10.2147/COPD.S35990

Ejemplares similares